Proteomics in uremia and renal disease

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 409-416

  Mischak, Harald ^c   Massy, Ziad A ^a   Jankowski, Joachim ^b  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MOSAIQUES DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAPILLARY ELECTROPHORESIS; HUMAN; MASS SPECTROMETRY; METABOLISM; PROTEOMICS; UREMIA;

ELECTROPHORESIS, CAPILLARY; HUMANS; MASS SPECTROMETRY; PROTEOMICS; UREMIA;

EID: 69249154604     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00591.x     Document Type: Article

References (40)

1. Anderson NL, Anderson NG : The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1 : 845 867, 2002
2. Lescuyer P, Hochstrasser D, Rabilloud T : How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res 6 : 3371 3376, 2007
3. Mischak H, Apweiler R, Banks RE, Conaway M, Coon JJ, Dominizak A, Ehrich JH, Fliser D, Girolami M, Hermjakob H, Hochstrasser DF, Jankowski V, Julian BA, Kolch W, Massy Z, Neususs C, Novak J, Peter K, Rossing K, Schanstra JP, Semmes OJ, Theodorescu D, Thongboonkerd V, Weissinger EM, Van Eyk JE, Yamamoto T : Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl 1 : 148 156, 2007
4. Abdi H : Bonferroni and Sidak Corrections for Multiple Comparisons. Thousand Oaks, CA : Sage, 2007
5. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami M, Jankowski J, Mischak H : Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18 : 1057 1071, 2007
6. Kolch W, Neususs C, Pelzing M, Mischak H : Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 24 : 959 977, 2005
7. Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, Frommberger M, Golovko I, Good DM, Herget-Rosenthal S, Jankowski J, Julian BA, Kellmann M, Kolch W, Massy Z, Novak J, Rossing K, Schanstra JP, Schiffer E, Theodorescu D, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P : CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl 2 : 964 973, 2008
8. Zurbig P, Renfrow M.B., Schiffer E, Novak J, Walden M, Wittke S, Just I, Pelzing M, Neususs C, Theodorescu D, Root C, Ross M, Mischak H : Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27 : 2111 2125, 2006
9. Rao PV, Lu X, Standley M, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT Jr, Nagalla SR : Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 30 : 629 637, 2007
10. Shen Y, Kim J, Strittmatter EF, Jacobs JM, Camp DG, Fang R, Tolie N, Moore RJ, Smith RD : Characterization of the human blood plasma proteome. Proteomics 5 : 4034 4045, 2005 (Pubitemid 41502498)
11. Temporini C, Calleri E, Massolini G, Caccialanza G : Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins. Mass Spectrom Rev 27 : 207 236, 2008
12. Guerrier L, Claverol S, Fortis F, Rinalducci S, Timperio AM, Antonioli P, Jandrot-Perrus M, Boschetti E, Righetti PG : Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. J Proteome Res 6 : 4290 4303, 2007
13. Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmueller H, Ruschoff J, Henkel T, Rohr G, Rossol S, Rosch W, Langen H, Zolg W, Tacke Mo : Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 5 : 2092 2101, 2006
14. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P : Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 65 : 323 332, 2004
15. Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, Mischak H, Frierson HF : Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 7 : 230 240, 2006
16. Theodorescu D, Fliser D, Wittke S, Mischak H, Krebs R, Walden M, Ross M, Eltze E, Bettendorf O, Wulfing C, Semjonow A : Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 26 : 2797 2808, 2005
17. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Golovko I, Rupprecht HD, Haubitz M, Hecker H, Mischak H, Fliser D : Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 65 : 2426 2434, 2004
18. Thongboonkerd V : Practical points in urinary proteomics. J Proteome Res 6 : 3881 3890, 2007
19. Mischak H, Julian BA, Novak J : High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine. Proteomics Clin Appl 1 : 792 804, 2007
20. Issaq HJ, Chan KC, Janini GM, Conrads TP, Veenstra TD : Multidimensional separation of peptides for effective proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 817 : 35 47, 2005
21. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del BP, Pavone B, Perfumo F, Urbani A, Scolari F, Ghiggeri GM : Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 17 : 3139 3148, 2006
22. McLerran D, Grizzle WE, Feng Z, Thompson IM, Bigbee WL, Cazares LH, Chan DW, Dahlgren J, Diaz J, Kagan J, Lin DW, Malik G, Oelschlager D, Partin A, Randolph TW, Sokoll L, Srivastava S, Srivastava S, Thornquist M, Troyer D, Wright GL, Zhang Z, Zhu L, Semmes OJ : SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem 54 : 53 60, 2008
23. Decramer S, Gonzalez de PA, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP : Urine in clinical proteomics. Mol Cell Proteomics 7 : 1850 1862, 2008
24. Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H : Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 6 : 4549 4555, 2007
25. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H : Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 67 : 2313 2320, 2005
26. Neuhoff N, Kaiser T, Wittke S, Krebs R, Pitt A, Burchard A, Sundmacher A, Schlegelberger B, Kolch W, Mischak H : Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 18 : 149 156, 2004
27. Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sykora J, Sladkova E, Hes O, Mischak H, McGuire BM : Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis 28 : 4469 4483, 2007
28. Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P : Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 19 : 1283 1290, 2008
29. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM : Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 18 : 913 922, 2007
30. Decramer S, Wittke S, Mischak H, Zürbig P, Walden M, Bouissou F, Bascands JL, Schanstra JP : Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 12 : 398 400, 2006
31. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D : Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 107 : 485 495, 2004
32. Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, Danne T, Haller H, Fliser D, Mischak H : Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complicat 19 : 223 232, 2005
33. Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, Rewers M, Mischak H : Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther 11 : 1 9, 2009.
34. Rossing K, Mischak H, Rossing P, Schanstra JP, Wiseman A, Maahs DM : The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics Clin Appl 2 : 997 1007, 2008
35. Weissinger EM, Kaiser T, Meert N, De Smet R, Walden M, Mischak H, Vanholder RC : Proteomics: a novel tool to unravel the patho-physiology of uraemia. Nephrol Dial Transplant 19 : 3068 3077, 2004
36. Adermann K, John H, Standker L, Forssmann WG : Exploiting natural peptide diversity: novel research tools and drug leads. Curr Opin Biotechnol 15 : 599 606, 2004
37. Molina H, Bunkenborg J, Reddy GH, Muthusamy B, Scheel PJ, Pandey A : A proteomic analysis of human hemodialysis fluid. Mol Cell Proteomics 4 : 637 650, 2005
38. Kaiser T, Hermann A, Kielstein JT, Wittke S, Bartel S, Krebs R, Hausadel F, Hillmann M, Golovko I, Koester P, Haller H, Weissinger EM, Fliser D, Mischak H : Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. J Chromatogr A 1013 : 157 171, 2003
39. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, Mischak H, Drueke TB, Lacour B, Massy ZA : Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics 6 : 993 1000, 2006
40. Schena FP, Gesualdo L : Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16 (Suppl. 1 S30 S33, 2005